tiprankstipranks
Advertisement
Advertisement

OCGN Stock Latest News

Ocugen price target lowered to $11 from $12 at Canaccord
The FlyOcugen price target lowered to $11 from $12 at Canaccord
15h ago
OCGN
5 Healthcare Stocks Set to Join the Russell 3000
PremiumMarket News
5 Healthcare Stocks Set to Join the Russell 3000
1d ago
QSI
AGEN
Ocugen Raises $130 Million Through Convertible Notes Offering
PremiumCompany Announcements
Ocugen Raises $130 Million Through Convertible Notes Offering
13d ago
8K
OCGN
Ocugen Announces Interim Chief Medical Officer Appointment Transition
PremiumCompany Announcements
Ocugen Announces Interim Chief Medical Officer Appointment Transition
13d ago
8K
OCGN
Ocugen Maintained at Buy as Analyst Cites Compelling Gene Therapy Data and Keeps $12 Price Target Unchanged
PremiumRatings
Ocugen Maintained at Buy as Analyst Cites Compelling Gene Therapy Data and Keeps $12 Price Target Unchanged
17d ago
OCGN
Ocugen Raises Capital Through Convertible Senior Notes Offering
PremiumCompany AnnouncementsOcugen Raises Capital Through Convertible Senior Notes Offering
20d ago
8K
OCGN
Ocugen Advances Late-Stage Gene Therapies, Bolsters Cash Runway
Premium
Company Announcements
Ocugen Advances Late-Stage Gene Therapies, Bolsters Cash Runway
22d ago
8K
OCGN
Ocugen reports Q1 EPS (6c), consensus (5c)
Premium
The Fly
Ocugen reports Q1 EPS (6c), consensus (5c)
23d ago
OCGN
Ocugen Announces Private Convertible Notes Offering to Deleverage
PremiumCompany Announcements
Ocugen Announces Private Convertible Notes Offering to Deleverage
23d ago
8K
OCGN
Ocugen announces private offering of $115M of convertible senior notes
PremiumThe Fly
Ocugen announces private offering of $115M of convertible senior notes
23d ago
OCGN
Ocugen: Buy Rating Reiterated as Analyst Highlights Retinal Pipeline Upside and Maintains $12 Price Target
PremiumRatings
Ocugen: Buy Rating Reiterated as Analyst Highlights Retinal Pipeline Upside and Maintains $12 Price Target
26d ago
OCGN
OCGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
OCGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
29d ago
OCGN
Ocugen completes dosing in GARDian3 trial
PremiumThe FlyOcugen completes dosing in GARDian3 trial
2M ago
OCGN
Chardan sees positive read-through to Annexon’s vonaprument from Apellis deal
Premium
The Fly
Chardan sees positive read-through to Annexon’s vonaprument from Apellis deal
2M ago
ANNX
APLS
Ocugen Updates Roadmap for Gene-Agnostic Retinal Therapies
Premium
Company Announcements
Ocugen Updates Roadmap for Gene-Agnostic Retinal Therapies
2M ago
8K
OCGN
Ocugen: Encouraging Phase 2 OCU410 Data in Geographic Atrophy Underpin Buy Rating and Long-Term Upside Potential
PremiumRatings
Ocugen: Encouraging Phase 2 OCU410 Data in Geographic Atrophy Underpin Buy Rating and Long-Term Upside Potential
2M ago
OCGN
Ocugen price target raised to $12 from $8 at Noble Capital
PremiumThe Fly
Ocugen price target raised to $12 from $8 at Noble Capital
2M ago
OCGN
Ocugen price target raised to $10 from $7 at H.C. Wainwright
PremiumThe Fly
Ocugen price target raised to $10 from $7 at H.C. Wainwright
2M ago
OCGN
Ocugen Reports Positive Phase 2 Data for OCU410 Therapy
PremiumCompany Announcements
Ocugen Reports Positive Phase 2 Data for OCU410 Therapy
2M ago
8K
OCGN
Midday Fly By: Estee Lauder in deal talks with Puig, Smithfield reports Q4 beat
PremiumThe FlyMidday Fly By: Estee Lauder in deal talks with Puig, Smithfield reports Q4 beat
2M ago
EL
RL
Ocugen announces 12-month data from ArMaDa clinical trial of OCU410
Premium
The Fly
Ocugen announces 12-month data from ArMaDa clinical trial of OCU410
2M ago
OCGN
TTD, OCGN, STZ, VRTX, LCID Trending With Analysts
Premium
Weekend Updates
TTD, OCGN, STZ, VRTX, LCID Trending With Analysts
2M ago
STZ
TTD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >